Thomas Jaki

53PUBLICATIONS
145CO-AUTHORS
Medical virologyPharmaceutical delivery technologiesMedical genetics (excl. cancer genetics)Cancer geneticsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Mar 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance Bias.

Martin J Wolfsegger, Peixin Xu, Amy Cotterill

|Dec 10, 2025
Group-Sequential Designs With an Externally-Driven Change of Primary Endpoint.

Amin Yarahmadi, Lori E Dodd, Peter Horby

|Dec 05, 2025
Joint time-to-event partial order continual reassessment method and Joint time-to-event Bayesian logistic regression model: Statistical designs for dual agent phase I/II dose finding studies with late-onset toxicity and activity outcomes.

Helen Barnett, Oliver Boix, Dimitris Kontos

|Jul 01, 2025
Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology.

Xijin Chen, Pavel Mozgunov, Richard D Baird

Pageof 9

Frequent Collaborators

15 joint publications

Pavel Mozgunov

7 joint publications

Franz König

6 joint publications

Munyaradzi Dimairo

5 joint publications

Christina Yap